Cochrane systematic review of directly observed therapy for treating tuberculosis: good analysis of the wrong outcome.
Rusen
I D
ID
International Union Against Tuberculosis and Lung Disease, Paris, France. rusen-steele@sympatico.ca
Aït-Khaled
Nadia
N
Alarcón
Edith
E
Billo
Nils
N
Bissell
Karen
K
Boillot
François
F
Caminero
José
J
Chiang
Chen-Yuan
CY
Clevenbergh
Philippe
P
Dhliwayo
Panganai
P
Dlodlo
Riitta
R
Enarson
Donald A
DA
Ferroussier
Odile
O
Fujiwara
Paula I
PI
Heldal
Einar
E
Hinderaker
Sven Gudmund
SG
Kim
Sang Jae
SJ
Lienhardt
Christian
C
Rieder
Hans L
HL
Trébucq
Arnaud
A
Van Deun
Armand
A
Wilson
Nevin
N
D006801:Humans; D000995:Antitubercular Agents / Q000494:pharmacology / Q000627:therapeutic use; D023801:Directly Observed Therapy; D004352:Drug Resistance, Microbial; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D012293:Rifampin / Q000494:pharmacology / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D000078202:Systematic Reviews as Topic
D000995:Antitubercular Agents; D012293:Rifampin